Alpine Woods Capital Investors’s ResMed RMD Stock Holding History

Alpine Woods Capital Investors’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-15,000	Closed	-$1.08M	–	473
2015 Q1	$1.08M	Hold	15,000	–	–	0.05%	251
2014 Q4	$841K	Hold	15,000	–	–	0.04%	264
2014 Q3	$739K	Hold	15,000	–	–	0.04%	281
2014 Q2	$759	Hold	15,000	–	–	0.02%	262
2014 Q1	$670K	Hold	15,000	–	–	0.04%	260
2013 Q4	$706K	Hold	15,000	–	–	0.04%	247
2013 Q3	$792K	Hold	15,000	–	–	0.05%	220
2013 Q2	$677K	Buy	+15,000	New	+$712K	0.04%	222

Other funds holding RMD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alpine Woods Capital Investors's RMD Position: Q2 2015 in Review

Alpine Woods Capital Investors sold out of ResMed (RMD) in Q2 2015, closing a stake of 15,000 shares — an estimated $1.08M sold.

Alpine Woods Capital Investors first reported a position in RMD in Q2 2013 and held it in 8 quarters. The position peaked at $1.08M in Q1 2015. 313 funds tracked by Wall St. Rank hold RMD as of Q2 2015.

Alpine Woods Capital Investors reported no remaining ResMed position as of Q2 2015 after selling out during the quarter.
Alpine Woods Capital Investors sold 15,000 ResMed shares in Q2 2015, an estimated $1.08M.
Alpine Woods Capital Investors first reported a position in ResMed in Q2 2013 and held it in 8 quarters.
Alpine Woods Capital Investors's ResMed position peaked at $1.08M in Q1 2015.
313 funds tracked by Wall St. Rank held ResMed as of Q2 2015.

Based on Alpine Woods Capital Investors's 13F filing for Q2 2015, filed 6 Aug 2015.